Ross Muken
Stock Analyst at Evercore ISI Group
(1.66)
# 3,446
Out of 5,141 analysts
49
Total ratings
46.43%
Success rate
-3.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $260 → $200 | $168.92 | +18.40% | 11 | Feb 19, 2026 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $79.57 | -12.03% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $99.70 | +140.72% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $122.90 | +5.78% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $48.57 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $224.44 | -70.15% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $117.67 | +112.46% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $510.93 | -56.94% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $9.05 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Feb 19, 2026
Maintains: Outperform
Price Target: $260 → $200
Current: $168.92
Upside: +18.40%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $79.57
Upside: -12.03%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $99.70
Upside: +140.72%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $122.90
Upside: +5.78%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $48.57
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $224.44
Upside: -70.15%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $117.67
Upside: +112.46%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $510.93
Upside: -56.94%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $9.05
Upside: -